Immune responses against CML-specific and CML-associated antigens such as BCR-ABL1, proteinase-3, and WT-1 can be detected in CML patients, suggesting it sensitivity to immune control. The gene discussed is WT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.